Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
479.00    2.00 (0.42%)
Bid:
477.00
Ask:
480.00
Spread: 3.00 (0.629%)
Market Cap: £790.42m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Holding(s) in Company

11 Nov 2009 11:55

RNS Number : 3440C
Oakley Capital Investments Limited
11 November 2009
Β 

ο»Ώ

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:Β ii

Oakley Capital Investments Ltd

2 Reason for the notificationΒ (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

No

An acquisition or disposal ofΒ qualifyingΒ financial instruments which may result in theΒ acquisition of shares already issuedΒ to which voting rights are attached

No

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

No

An event changing the breakdown of voting rights

No

Other (please specify):

ISC Adjustment

Yes

3. Full name of person(s) subject to the notification obligation:Β iii

Gartmore Investment Limited

4. Full name of shareholder(s)Β Β (if differentΒ from 3.):iv

See attached schedule

5. Date of the transaction and date on which the threshold is crossed or reached:Β v

23rdΒ October 2009

6.Β Date on which issuer notified:

26thΒ October 2009

7. Threshold(s) that is/are crossed or reached:Β vi, vii

13%

Β Β 

8. Notified details:

A: Voting rights attached to sharesΒ viii, ix

Class/type of shares

if possible using the ISIN CODE

Situation previous to theΒ triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rightsΒ x

Direct

DirectΒ xi

IndirectΒ xii

Direct

Indirect

BMG670131058

14,360,946

14,360,946

14,360,946

14,360,946

11.209%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration dateΒ xiii

Exercise/Β  Conversion PeriodΒ xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial InstrumentsΒ xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration dateΒ xvii

Exercise/ Conversion periodΒ xviii

Number of voting rights instrument refers to

% of voting rightsΒ xix, xx

Warrants

N/A

N/A

N/A

2,099,871

Nominal

Delta

1.639%

Total (A+B+C)

Number of voting rights

PercentageΒ of voting rights

16,460,817

12.487%

Β Β 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:Β xxi

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

All figures are based on the Company's issued share capital of 128,125,000 as provided by Exshare

E mail contact RDU@Gartmore.com

14. Contact name:

RDU

15. Contact telephone number:

020 7782 2324

Β Β 

Note:Β Annex should only be submitted to the FSA not the issuer

Annex: Notification of major interests in share

A: Identity of the persons or legal entity subject to the notification obligation

Full nameΒ 

(including legal form of legal entities)

Contact addressΒ 

(registered office for legal entities)

Phone numberΒ & email

Other useful informationΒ 

(at least legal representative for legal persons)

B: Identity of the notifier, if applicable

Full name

Mark Suchopar

Contact address

TheΒ EconomistΒ Building

8thΒ Floor

25 St James's Street

London

SW1A 1HA

Phone numberΒ & email

020 7766 6917

Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

C: Additional information

For notes on how to complete form TR-1 please see the FSA website.Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
HOLBBBBTMMABBTL
Date   Source Headline
29th Jun 20267:00 amRNSTransaction in Own Shares
24th Jun 20267:27 amRNSTransaction in Own Shares
19th Jun 20267:01 amRNSTransaction in Own Shares
17th Jun 20267:00 amRNSTransaction in Own Shares
15th Jun 20267:00 amRNSTransaction in Own Shares
10th Jun 20267:00 amRNSTransaction in Own Shares
9th Jun 20267:00 amRNSTotal Voting Rights
3rd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20264:51 pmRNSResult of AGM
1st Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSOakley Capital invests in XTEL
21st May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSNotice of AGM
1st May 20267:00 amRNSTotal Voting Rights
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTrading update for the 3 months ended 31 March 26
24th Apr 20267:00 amRNSDirector Dealing
1st Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSStandard form for notification of major holdings
17th Mar 20267:00 amRNSOakley Capital partners with Groupe Senef
17th Mar 20267:00 amRNSOakley Capital partners with Groupe Senef
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSFinal Results for the Year Ended 31 December 2025
12th Mar 20267:00 amRNSFinal Results for the Year Ended 31 December 2025
10th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSNotice of Results and Investor Presentation
3rd Mar 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSDirector Dealing
17th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 202612:05 pmRNS-RUpdate from QuotedData
11th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20263:26 pmRNSStandard form for notification of major holdings
6th Feb 20263:26 pmRNSStandard form for notification of major holdings
6th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20269:43 amRNS-RUpdate from QuotedData
4th Feb 20267:00 amRNSDirector Dealing
2nd Feb 20267:00 amRNSTotal Voting Rights
28th Jan 20267:00 amRNSTrading update for the year ended 31 December 2025
26th Jan 20267:00 amRNSStandard form for notification of major holdings
9th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20265:49 pmRNSStandard form for notification of major holdings
5th Jan 20267:00 amRNSOakley Capital invests in GLAS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.